---
figid: PMC3960720__nihms-562625-f0008
figlink: /pmc/articles/PMC3960720/figure/F8/
number: Figure 8
caption: ErbB4 agonists and antagonists stimulate the formation of EGFR–ErbB4 heterodimers
  that possess distinct conformations. Thus ErbB4 agonists and antagonists stimulate
  ErbB4 tyrosine phosphorylation on distinct sets of tyrosine residues. (A) This could
  result in differences in ErbB4 coupling to the PI3K/Akt signalling pathway. (B)
  This could result in differences in ErbB4 coupling to the transcriptional co-regulator
  YAP. (C) This could result in differences in ErbB4 degradation and turnover.
pmcid: PMC3960720
papertitle: The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
reftext: Kristy J. Wilson, et al. Biochem J. ;443(1):133-144.
pmc_ranked_result_index: '51365'
pathway_score: 0.9624834
filename: nihms-562625-f0008.jpg
figtitle: Q43L mutant of neuregulin 2B is a pan-ErbB receptor antagonist
year: ''
organisms: Homo sapiens
ndex: fe0f28c2-deb3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3960720__nihms-562625-f0008.html
  '@type': Dataset
  description: ErbB4 agonists and antagonists stimulate the formation of EGFR–ErbB4
    heterodimers that possess distinct conformations. Thus ErbB4 agonists and antagonists
    stimulate ErbB4 tyrosine phosphorylation on distinct sets of tyrosine residues.
    (A) This could result in differences in ErbB4 coupling to the PI3K/Akt signalling
    pathway. (B) This could result in differences in ErbB4 coupling to the transcriptional
    co-regulator YAP. (C) This could result in differences in ErbB4 degradation and
    turnover.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB4
  - PIK3CG
  - PIK3R3
  - EGFR
  - YY1AP1
  - AKT3
  - CEACAM5
  - PIK3CD
  - PDK4
  - PIK3R6
  - AKT2
  - NRG2
  - PIK3CA
  - PDK1
  - PDK2
  - PIK3CB
  - AKT1
  - PIK3R4
  - PIK3R5
  - PDK3
  - Cancer
genes:
- word: ErbB4
  symbol: ERBB4
  source: hgnc_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CE-a
  symbol: CEA
  source: hgnc_prev_symbol
  hgnc_symbol: CEACAM5
  entrez: '1048'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NRG2
  symbol: NRG2
  source: hgnc_symbol
  hgnc_symbol: NRG2
  entrez: '9542'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
